echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Medical Insurance Bureau officially listed for nearly a year, affecting the fate of a large number of pharmaceutical enterprises!

    Medical Insurance Bureau officially listed for nearly a year, affecting the fate of a large number of pharmaceutical enterprises!

    • Last Update: 2019-05-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [industry trends of pharmaceutical Station] it's nearly a year since the official listing of the State Health Insurance Bureau on May 31, 2018 In this year, from drug pricing, drug bidding, to drug medical insurance, whether the common people can enjoy the benefits or not, every link is changing, and has affected the fate of a large number of pharmaceutical enterprises Specifically, it can be divided into the following aspects The national drug price negotiation continued to advance The national drug price negotiation in 2015 and the national medical insurance catalog access negotiation policies in 2017 and 2018 were continued According to the plan, a new round of national negotiations on some varieties of medical insurance catalog will be launched in June 2019, and the negotiation access catalog will be released in August According to the industry, whether the main products of pharmaceutical enterprises can enter the medical insurance drug catalog directly determines the sales volume of pharmaceutical enterprises Among them, access to the medical insurance catalog can quickly achieve market volume, while being transferred out means that market space will be squeezed "4 + 7" pilot will be popularized nationwide On April 1, 11 pilot cities with "4 + 7" volume procurement in China will be launched in an all-round way It is reported that as of April 14, the total purchase amount of 25 selected varieties in the first round of belt purchase in the pilot area reached 438 million pieces, with a total amount of 533 million yuan, 27.31% of the total agreed purchase amount Relevant state departments said that the "4 + 7" pilot project is expected to be promoted nationwide According to the industry news, the second batch of 4 + 7 volume purchase plans and plans are expected to be released in June this year, and will be implemented in October The industry said that under the influence of volume purchasing, drug companies have become a major trend in price reduction In addition, it is inevitable for many pharmaceutical enterprises to shift their sales focus to the outside of hospital, and the market of prescription outflow will blow out According to industry estimates, by 2020, the market share of prescription outflow can reach 400 billion yuan Adjustment of the national medical insurance catalog on March 13, the National Medical Insurance Bureau issued the work plan for the adjustment of the national medical insurance drug catalog in 2019 (Draft for comments), which made provisions for the types of drugs to be included preferentially, and more life-saving drugs are expected to be included in the scope of the medical insurance catalog The adjustment of drug catalog involves three aspects: Western medicine, Chinese patent medicine and Chinese herbal medicine The scope of medical insurance catalog will be appropriately expanded according to the fund payment capacity, and efforts will be made to optimize the drug structure and improve the efficiency of medical insurance fund use In the aspect of transfer in, drugs with consistency evaluation, sufficient evidence-based clinical evidence and low price are more likely to enter the market In terms of transfer out, the original drugs in the drug catalog, if they have been prohibited from production, sale and use by the national drug regulatory authorities, shall be transferred out; other drugs that do not meet the requirements and conditions of medical insurance drugs, can be transferred out after corresponding review procedures According to this document, it can be seen that a new round of adjustment of the medical insurance catalogue is in progress Launch DRGs national pilot It is reported that China has been exploring DRGs for nearly 30 years In December 2018, the state health insurance bureau issued the notice on the pilot countries applying for payment by disease diagnosis related groups, which pointed out that the health insurance bureau is studying and developing the DRGs standard suitable for China's medical service system and medical insurance management capacity, and launching the DRGs payment pilot in some cities, Provinces can recommend 1-2 cities as national pilot candidates It is worth noting that this is a cross medical insurance and medical exploration led by the medical insurance bureau, which is conducive to the formulation and improvement of the basically unified DRGs payment policies, processes and technical standards and specifications, and the formation of pilot results that can be used for reference, copied and promoted On the whole, the reform of health insurance has already affected many pharmaceutical enterprises, and where will the future health insurance go? It's about the fate of every pharmaceutical company, which needs to be paid close attention to.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.